Lilly Set To Hand Over $1.4B Zyprexa Payout: Report

By Erin Marie Daly

Law360, New York (January 14, 2009, 12:00 AM ET) -- Eli Lilly & Co. is reportedly one step closer to finalizing a $1.4 billion settlement with the U.S. Attorney's Office for the Eastern District of Pennsylvania and 30 states regarding the company's promotion and marketing of the anti-psychotic treatment Zyprexa.

The Indiana-based drugmaker, which set aside the amount in the third quarter of 2008 to brace for a possible settlement that would resolve Zyprexa-related federal claims and Medicaid-related claims, may agree to the deal as soon as Thursday, the New York Times reported Wednesday.

Angela Sekston,...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles